SWM
ARNA

SeaCrest Wealth Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

SeaCrest Wealth Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200
Closed -$9K – 2042
2019
Q1 		$9K Hold
200
– – ﹤0.01% 1578
2018
Q4 		$8K Hold
200
– – ﹤0.01% 1572
2018
Q3 		$9K Buy
200
+100
+100% +$4.05K ﹤0.01% 1704
2018
Q2 		$4K Hold
100
– – ﹤0.01% 1903
2018
Q1 		$4K Buy
+100
New +$3.89K ﹤0.01% 1865

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

SeaCrest Wealth Management's ARNA Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2019, closing a stake of 200 shares — an estimated $9K sold.

SeaCrest Wealth Management first reported a position in ARNA in Q1 2018 and held it in 5 quarters. The position peaked at $9K in Q1 2019. 215 funds tracked by Wall St. Rank hold ARNA as of Q2 2019.

  • SeaCrest Wealth Management reported no remaining Arena Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
  • SeaCrest Wealth Management sold 200 Arena Pharmaceuticals Inc shares in Q2 2019, an estimated $9K.
  • SeaCrest Wealth Management first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 5 quarters.
  • SeaCrest Wealth Management's Arena Pharmaceuticals Inc position peaked at $9K in Q1 2019.
  • 215 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.